Avinger initiates full commercial launch of tigereye(tm) image-guided cto crossing catheter

Redwood city, ca / accesswire / january 15, 2021 / avinger, inc. (nasdaq:avgr), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of peripheral artery disease (pad), today announced full commercial launch of its tigereye™ image-guided chronic total occlusion (cto) crossing system. with the initiation of full commercial launch, current and prospective accounts throughout the us and germany are now able to order the tigereye device.
AVGR Ratings Summary
AVGR Quant Ranking